Oracle to buy drug software company Phase Forward
Software maker Oracle Corp is set to buy drug data management software company Phase Forward for about $685 million, the companies said on Friday.
Oracle recently announced that it has agreed to acquire Phase Forward, a provider of e-clinical and drug safety solutions.